Reading MCK? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track MCK free→Reading MCK? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track MCK free→QuarterlyIQ Insights · MCK
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Entry into a Material Definitive Agreement. On June 9, 2026, certain of McKesson Corporation’s (the “Company”) subsidiaries, including McKesson Medical-Surgical Top Holdings, Inc. (the “Borrower”), entered into an amendment (the “Amendment”) to the Credit Agreement , dated as of April 1, 2026, among, the Borrower, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (as so amended, the “Credit Agreement”), to provide for a $2,…
Results of Operations and Financial Condition. On May 7, 2026, McKesson Corporation (the “Company”) reported the Company’s preliminary results for the quarter and fiscal year ended on March 31, 2026 which are attached hereto as Exhibit 99.1. The information contained in this Form 8-K, including Exhibit 99.1, is furnished to the Securities and Exchange Commission (the “Commission”), but shall not be deemed “filed” with the Commission for purposes of Section 18 of the Securities Exchange Act of…
Entry into a Material Definitive Agreement. On April 24, 2026, McKesson Corporation (“McKesson” or the “Company”) entered into a Credit Agreement (the “New Revolving Credit Facility”) among the Company, as borrower, the lenders party thereto, Bank of America, N.A., as administrative agent, and the other parties thereto. The New Revolving Credit Facility replaces the Company’s existing $1.0 billion 364-day senior unsecured revolving credit facility, dated as of May 8, 2025 (the “Existing 364-D…
I tem 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information in
Entry into a Material Definitive Agreement. On April 1, 2026, certain of McKesson Corporation’s (the “Company”) subsidiaries, including McKesson Medical-Surgical Top Holdings, Inc. (the “Borrower”), entered into a credit agreement (the “Credit Agreement”) with the lenders and issuing banks party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent providing for (i) a $750.0 million senior secured term “A” loan facility due 2031 (the “Term Loan A-1 Facility”), (i…
Chief Financial Officer — Britt J. Vitalone: The CFO is retiring and a new CFO has been appointed.
Results of Operations and Financial Condition. On February 4, 2026, McKesson Corporation (the “Company”) reported the Company’s preliminary results for the quarter ended on December 31, 2025 which are attached hereto as Exhibit 99.1. The information contained in this Form 8-K, including Exhibit 99.1, is furnished to the Securities and Exchange Commission (the “Commission”), but shall not be deemed “filed” with the Commission for purposes of Section 18 of the Securities Exchange Act of 1934, a…
Regulation FD Disclosure. Today, June 9, 2025, McKesson Corporation's (McKesson) executives are scheduled to meet with various investors and analysts. During these meetings, they will discuss McKesson’s growth strategies, operational performance, business and market trends and financial outlook. Today, McKesson is providing the following updates to its Fiscal Year 2026 Financial Outlook. McKesson is increasing its full year Adjusted Earnings per Diluted Share guide from a range of $36.75 to $…
Regulation FD Disclosure. McKesson Corporation participated in the Wells Fargo 2024 Healthcare Conference on September 5, 2024, as previously noticed in the company’s August 7, 2024 earnings release and on its investor relations website investor.mckesson.com. During the conference webcast, McKesson affirmed fiscal 2025 full year Adjusted Earnings per Diluted Share guidance in the range of $31.75 to $32.55. McKesson also indicated it anticipates second quarter fiscal 2025 Adjusted earnings per…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 29, 2023, Nancy Avila, Executive Vice President, Chief Information Officer and Chief Technology Officer stepped down from her role and as an executive officer of the Company effective October 2, 2023. Avila has agreed to continue employment with the Company through January 1, 2024, to assist with transition activities. SIGNATURES Pursu…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Severance Policy for Executive Employees On April 26, 2022, Compensation Committee (the “Compensation Committee”) of the Board of Directors (the “Board”) of McKesson Corporation (“Company”) adopted the Amended and Restated McKesson Corporation Severance Policy for Executive Employees (as so amended and restated, the “Executive Severance Policy”). T…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On February 21, 2022, Napoleon B. Rutledge, Jr., 49, was appointed as Senior Vice President, Controller and Chief Accounting Officer of McKesson Corporation ("Company") for the term of office provided by Article IV of the Company's By-Laws. Before joining the Company effective March 1, 2022 ("Hire Date"), Mr. Rutledge worked for Genuine Parts Compan…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 4, 2021, Kenneth E. Washington informed the Board of Directors (Board) of McKesson Corporation (Company) of his intent to resign as a Director of the Company. Dr. Washington resigned effective on October 5, 2021. Dr. Washington served as a Director of the Company since July 2019 and was a member of the Audit Committee and the Compliance…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On September 10, 2021, Kevin W. Emerson was appointed as Senior Vice President, Controller and Chief Accounting Officer of McKesson Corporation (“McKesson” or the “Company”) on an interim basis while the Company completes its search process for a permanent replacement for this position. Mr. Emerson, age 49, joined McKesson in 2005 and has held many…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On August 13, 2021, McKesson Corporation (“Company”) received notice from Sundeep G. Reddy of his intention to resign as principal accounting officer of the Company effective on September 10, 2021 in order to pursue another employment opportunity. At that time, Kevin W. Emerson will be appointed as interim principal accounting officer.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.